Autumn Gertz

Ms. Autumn Gertz

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2022 in Preventive Medicine Reports
Verified
Journal Article
Open access
AGAutumn Gertz
Autumn Gertz
CPCatherine C. Pollack
Catherine C. Pollack
MSMarinanicole D. Schultheiss
Marinanicole D. Schultheiss
JBJohn S. Brownstein
John S. Brownstein
• An online cross-sectional survey administered twice during the COVID-19 pandemic. • Those with poor health were more likely to delay care than those with good health. • Those with underlying conditions were more likely to delay medical care. • Across underlying conditions, odds of delaying care increased between 2020 and 2021.

14 January 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
AGAutumn Gertz
Autumn Gertz
BRBenjamin Rader
Benjamin Rader
KSKara Sewalk
Kara Sewalk
JBJohn S. Brownstein
John S. Brownstein
Although COVID-19 vaccination plans acknowledge a need for equity, disparities in two-dose vaccine initiation have been observed in the United States. We aim to assess if disparity patterns are emerging in COVID-19 vaccination completion. We gathered (n = 843,985) responses between February and November 2021 from a web survey. Individuals self-reported demographics and COVID-19 vaccination status. Dose initiation and completion rates were calculated incorporating survey weights. A multi-variate logistic regression assessed the association between income and completing vaccination, accounting for other demographics. Overall, 57.4% initiated COVID-19 vaccination, with 84.5% completing vaccination. Initiation varied by income, and we observed disparities in completion by occupation, race, age, and insurance. Accounting for demographics, higher incomes are more likely to complete vaccination than lower incomes. We observe disparities in completion across annual income. Differences in COVID-19 vaccination completion may lead to two tiers of protection in the population, with certain sub-groups being better protected from future infection.

1 March 2025 in American Journal of Public Health
Verified
Journal Article
Closed access
EZEric Geng Zhou
Eric Geng Zhou
JCJonathan Cantor
Jonathan Cantor
AGAutumn Gertz
Autumn Gertz
BEBrian Elbel
Brian Elbel
JBJohn S. Brownstein
John S. Brownstein
BRBenjamin Rader
Benjamin Rader
Objectives. To determine the association between parental characteristics and MMR (measles–mumps– rubella) vaccination status of children in the United States. Methods. We conducted a cross-sectional study from July 2023 to April 2024 using a digital health survey via OutbreaksNearMe, weighted to target national population characteristics. We analyzed the responses of 19 892 parents of children younger than 5 years to examine the association between self-reported parental characteristics (i.e., sociodemographics, politics, COVID-19 vaccination status) and children’s MMR vaccination rates using logistic regression. Results. Children of parents who received at least 1 dose of the COVID-19 vaccine had higher MMR vaccination rates (80.8%) than did children of unvaccinated parents (60.9%; odds ratio [OR] = 1.84; 95% confidence interval [CI] = 1.68, 2.00). We observed lower MMR vaccination rates among children of parents who identified as Republican versus Democratic (OR = 0.73; 95% CI = 0.64, 0.82), parents on Medicaid or Medicare versus private insurance (OR = 0.85; 95% CI = 0.76, 0.95), and minority (OR = 0.44) versus White (OR = 0.71) parents. We found higher MMR vaccination rates in the Northeast and Midwest United States. Conclusions. Early data indicate that parental sociodemographic characteristics and COVID-19 vaccine status are associated with children’s MMR vaccine uptake, emphasizing the need for further investigations into multipronged public health interventions. ( Am J Public Health. 2025;115(3):369–373. https://doi.org/10.2105/AJPH.2024.307912 )

28 December 2023 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
AGAutumn Gertz
Autumn Gertz
BRBenjamin Rader
Benjamin Rader
KSKara Sewalk
Kara Sewalk
TVTanner J Varrelman
Tanner J Varrelman
MSMark Smolinski
Mark Smolinski
JBJohn S. Brownstein
John S. Brownstein
Background: Seasonal respiratory viruses had lower incidence during their 2019-2020 and 2020-2021 seasons, which overlapped with the COVID-19 pandemic. The widespread implementation of precautionary measures to prevent transmission of SARS-CoV-2 has been seen to also mitigate transmission of seasonal influenza. The COVID-19 pandemic also led to changes in care seeking and access. Participatory surveillance systems have historically captured mild illnesses that are often missed by surveillance systems that rely on encounters with a health care provider for detection. Objective: This study aimed to assess if a crowdsourced syndromic surveillance system capable of detecting mild influenza-like illness (ILI) also captured the globally observed decrease in ILI in the 2019-2020 and 2020-2021 influenza seasons, concurrent with the COVID-19 pandemic. Methods: Flu Near You (FNY) is a web-based participatory syndromic surveillance system that allows participants in the United States to report their health information using a brief weekly survey. Reminder emails are sent to registered FNY participants to report on their symptoms and the symptoms of household members. Guest participants may also report. ILI was defined as fever and sore throat or fever and cough. ILI rates were determined as the number of ILI reports over the total number of reports and assessed for the 2016-2017, 2017-2018, 2018-2019, 2019-2020, and 2020-2021 influenza seasons. Baseline season (2016-2017, 2017-2018, and 2018-2019) rates were compared to the 2019-2020 and 2020-2021 influenza seasons. Self-reported influenza diagnosis and vaccination status were captured and assessed as the total number of reported events over the total number of reports submitted. CIs for all proportions were calculated via a 1-sample test of proportions. Results: ILI was detected in 3.8% (32,239/848,878) of participants in the baseline seasons (2016-2019), 2.58% (7418/287,909) in the 2019-2020 season, and 0.27% (546/201,079) in the 2020-2021 season. Both influenza seasons that overlapped with the COVID-19 pandemic had lower ILI rates than the baseline seasons. ILI decline was observed during the months with widespread implementation of COVID-19 precautions, starting in February 2020. Self-reported influenza diagnoses decreased from early 2020 through the influenza season. Self-reported influenza positivity among ILI cases varied over the observed time period. Self-reported influenza vaccination rates in FNY were high across all observed seasons. Conclusions: A decrease in ILI was detected in the crowdsourced FNY surveillance system during the 2019-2020 and 2020-2021 influenza seasons, mirroring trends observed in other influenza surveillance systems. Specifically, the months within seasons that overlapped with widespread pandemic precautions showed decreases in ILI and confirmed influenza. Concerns persist regarding respiratory pathogens re-emerging with changes to COVID-19 guidelines. Traditional surveillance is subject to changes in health care behaviors. Systems like FNY are uniquely situated to detect disease across disease severity and care seeking, providing key insights during public health emergencies.

22 June 2026 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
JSJuliana Sopko
Juliana Sopko
AHAimee R Han
Aimee R Han
JPJacqueline Powers
Jacqueline Powers
JSJacquelin A Sauer
Jacquelin A Sauer
MAMansi Avunoori
Mansi Avunoori
JBJohn S. Brownstein
John S. Brownstein
Background: Highly pathogenic avian influenza (HPAI) A(H5N1) clade 2.3.4.4b, a globally predominant strain, was introduced into poultry in the United States in 2022 via spillover from wild birds, and has since been regularly reported, posing ongoing risks to animal and human health. In 2024, the United States reported the first known HPAI A(H5N1) clade 2.3.4.4b infection in dairy cattle, rapidly evolving into a multispecies outbreak among cattle and poultry, with spillover into humans. Publicly available data remained siloed and fragmented, hindering timely response. Innovative multimodal surveillance methods can enhance situational awareness through comprehensive, standardized data collection, integration, and visualization. Objective: This study aimed to describe observations from the application of enhanced surveillance methods that collect, integrate, and visualize multimodal data for real-time tracking of the 2024‐2025 HPAI A(H5) outbreak in the United States as an innovative, transparent, repeatable, and scalable approach for open-source public health surveillance. Methods: Global.health conducted real-time, multimodal surveillance of the United States 2024‐2025 HPAI A(H5) outbreak using publicly available data for human cases (Centers for Disease Control and Prevention), animal outbreaks (United States Department of Agriculture), wastewater monitoring (WastewaterSCAN), genomic data (public genomic databases), research updates (scholarly communication), and policy changes and response measures (media and government) for the study period from February 1, 2024 through February 28, 2025. This digital data stream was used to create outbreak resources—an epidemiological linelist, event timeline, and interactive map—using a One Health framework to track emerging hotspots. Results: Global.health curated 70 confirmed human HPAI A(H5) cases across 13 states in a linelist, with exposure for nearly all (n = 65, 92.9%) cases associated with commercial agriculture and related operations. We curated 682 timeline entries across 6 distinct categories: human, cattle, response (eg, research, policy changes, and public health guidance), birds, genome, wastewater, and mammals. The map integrated human cases (n=70) and animal outbreaks (commercial cattle: n=977 and commercial poultry: n=325) into a single view. California was identified as the outbreak epicenter with high numbers of human cases (n=38, 54.3%), commercial cattle outbreaks (n=748, 76.6%), and commercial poultry outbreaks (n=66, 20.3%) during the study period. Wastewater surveillance detected the virus in California, with an unknown source at least 81 days before the first confirmed commercial dairy cattle case. Conclusions: Global.health’s approach for integrating traditional and nontraditional public health surveillance data within a One Health framework enhanced early situational awareness during the United States 2024‐2025 HPAI A(H5) outbreak, creating open access to resources that improve contextual understanding of the scope and evolution of this emerging zoonotic event. Further research should seek to understand the full potential of multimodal data in outbreak surveillance.

10 June 2026 in Health Affairs Scholar
Verified
Journal Article
Open access
BRBenjamin Rader
Benjamin Rader
AGAutumn Gertz
Autumn Gertz
JCJonathan Cantor
Jonathan Cantor
RMRyan K McBain
Ryan K McBain
JBJohn S Brownstein
John S Brownstein
Introduction: Generative AI (genAI) is rapidly entering healthcare, but public comfort may vary in ways that could undermine equitable adoption. Methods: Using two independent cross-sectional survey waves of US adults conducted in May 2023 (N = 3130) and November 2025 (N = 3088) on the Outbreaks Near Me participatory surveillance platform, we assessed changes in awareness of genAI and four comfort and perception measures. Results: The percentage of respondents reporting they had heard “a lot” about genAI rose from 26.5% (95% confidence interval [CI]: 24.5, 28.5) to 42.9% (95% CI: 40.6, 45.3), yet overall comfort with AI-led primary care and AI-led therapy changed minimally (−1.0 and −0.7% points, respectively). Subgroup trends diverged sharply by political identity, age, and race. Notably, Republicans trended more favorably from 2023 to 2025 while Democrats declined (interaction odds ratios across the four measures ranging from 1.69 [95% CI: 1.19, 2.39] to 2.11 [95% CI: 1.54, 2.90]). Conclusion: Emerging divides suggest receptivity to genAI in healthcare may become increasingly shaped by political identity rather than clinical evidence or personal experience, complicating equitable deployment.